Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats
- PMID: 15668802
- DOI: 10.1007/s00428-004-1175-1
Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats
Abstract
The early responses of the myocardium ultrastructure under thyroid dysfunction conditions, hemodynamic parameters, cardiac hypertrophy and ultrastructural evaluations were performed in hypothyroid and hyperthyroid rats submitted to different doses [T4-25 and T4-100; 0.025 mg and 0.1 mg kg(-1) body weight (BW).per day, respectively)]. All groups were treated for 7 days. The animals were sacrificed, the hearts were excised and weighed and the left ventricle tissue samples were processed for transmission election microscopy. Systolic blood pressure (SBP) was not altered by administration of T4. An increased heart rate and ratio of heart weight to body weight (HW/BW) were found in the hyperthyroid rats. However, the SBP and HW/BW decreased significantly in hypothyroid rats. No significant ultrastructural alterations were detected when the hypothyroid and T4-25 groups were compared with the control group. Alterations of cardiomyocytes nuclei of these groups were also not detected. Notably, disorganization of intercellular junctions was observed in many cardiomyocytes of T4-100 group. The present results indicate that in the early stages of hyperthyroidism, the cardiac hypertrophy development was mainly due to direct effects of thyroid hormone. Despite cardiac hypertrophy development, there is no ultrastructural evidence of myocardial degeneration.
Similar articles
-
Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density.Virchows Arch. 2006 Apr;448(4):472-9. doi: 10.1007/s00428-005-0140-y. Epub 2006 Jan 27. Virchows Arch. 2006. PMID: 16440199
-
Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function?J Mol Endocrinol. 1993 Jun;10(3):313-23. doi: 10.1677/jme.0.0100313. J Mol Endocrinol. 1993. PMID: 8373515
-
Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling.Am J Physiol Regul Integr Comp Physiol. 2003 Dec;285(6):R1473-80. doi: 10.1152/ajpregu.00269.2003. Epub 2003 Aug 21. Am J Physiol Regul Integr Comp Physiol. 2003. PMID: 12933361
-
Biochemical and physiologic effects of thyroid hormone on cardiac performance.Prog Cardiovasc Dis. 1983 Mar-Apr;25(5):435-64. doi: 10.1016/0033-0620(83)90004-x. Prog Cardiovasc Dis. 1983. PMID: 6221355 Review. No abstract available.
-
In vitro methods to study hypertrophy of cardiac cells.J Pharmacol Toxicol Methods. 1994 Sep;32(1):19-23. doi: 10.1016/1056-8719(94)90012-4. J Pharmacol Toxicol Methods. 1994. PMID: 7833502 Review. No abstract available.
Cited by
-
Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.Ther Adv Cardiovasc Dis. 2016 Aug;10(4):192-202. doi: 10.1177/1753944715623228. Epub 2015 Dec 28. Ther Adv Cardiovasc Dis. 2016. PMID: 26715125 Free PMC article.
-
Short-term thyroid hormone excess affects the heart but does not affect adrenal activity in rats.Arq Bras Cardiol. 2014 Mar;102(3):270-8. doi: 10.5935/abc.20140014. Epub 2014 Feb 10. Arq Bras Cardiol. 2014. PMID: 24676225 Free PMC article.
-
Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density.Virchows Arch. 2006 Apr;448(4):472-9. doi: 10.1007/s00428-005-0140-y. Epub 2006 Jan 27. Virchows Arch. 2006. PMID: 16440199
-
EFFECT OF ASTRAGALOSIDE ON VITAMIN D-RECEPTOR EXPRESSION AFTER ENDOTHELIN-1-INDUCED CARDIOMYOCYTE INJURY.Afr J Tradit Complement Altern Med. 2017 Jun 5;14(4):278-288. doi: 10.21010/ajtcam.v14i4.31. eCollection 2017. Afr J Tradit Complement Altern Med. 2017. PMID: 28638891 Free PMC article.
-
Global Disruption of α2A Adrenoceptor Barely Affects Bone Tissue but Minimizes the Detrimental Effects of Thyrotoxicosis on Cortical Bone.Front Endocrinol (Lausanne). 2018 Aug 28;9:486. doi: 10.3389/fendo.2018.00486. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30233491 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical